These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20880963)

  • 1. Thyronamines--past, present, and future.
    Piehl S; Hoefig CS; Scanlan TS; Köhrle J
    Endocr Rev; 2011 Feb; 32(1):64-80. PubMed ID: 20880963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.
    Scanlan TS; Suchland KL; Hart ME; Chiellini G; Huang Y; Kruzich PJ; Frascarelli S; Crossley DA; Bunzow JR; Ronca-Testoni S; Lin ET; Hatton D; Zucchi R; Grandy DK
    Nat Med; 2004 Jun; 10(6):638-42. PubMed ID: 15146179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of thyronamines on glucose metabolism in rats.
    Klieverik LP; Foppen E; Ackermans MT; Serlie MJ; Sauerwein HP; Scanlan TS; Grandy DK; Fliers E; Kalsbeek A
    J Endocrinol; 2009 Jun; 201(3):377-86. PubMed ID: 19273499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues.
    Hart ME; Suchland KL; Miyakawa M; Bunzow JR; Grandy DK; Scanlan TS
    J Med Chem; 2006 Feb; 49(3):1101-12. PubMed ID: 16451074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Iodothyronamine-A Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action.
    Köhrle J; Biebermann H
    Endocr Rev; 2019 Apr; 40(2):602-630. PubMed ID: 30649231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.
    Chiellini G; Bellusci L; Sabatini M; Zucchi R
    Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?
    Ianculescu AG; Scanlan TS
    Mol Biosyst; 2010 Aug; 6(8):1338-44. PubMed ID: 20623079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury.
    Doyle KP; Suchland KL; Ciesielski TM; Lessov NS; Grandy DK; Scanlan TS; Stenzel-Poore MP
    Stroke; 2007 Sep; 38(9):2569-76. PubMed ID: 17690312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An online solid-phase extraction-liquid chromatography-tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine.
    Ackermans MT; Klieverik LP; Ringeling P; Endert E; Kalsbeek A; Fliers E
    J Endocrinol; 2010 Sep; 206(3):327-34. PubMed ID: 20603264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells.
    Agretti P; De Marco G; Russo L; Saba A; Raffaelli A; Marchini M; Chiellini G; Grasso L; Pinchera A; Vitti P; Scanlan TS; Zucchi R; Tonacchera M
    J Mol Endocrinol; 2011 Aug; 47(1):23-32. PubMed ID: 21511808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of thyronamines.
    Zucchi R; Ghelardoni S; Chiellini G
    Heart Fail Rev; 2010 Mar; 15(2):171-6. PubMed ID: 19016324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyronamines are isozyme-specific substrates of deiodinases.
    Piehl S; Heberer T; Balizs G; Scanlan TS; Smits R; Koksch B; Köhrle J
    Endocrinology; 2008 Jun; 149(6):3037-45. PubMed ID: 18339710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.
    Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
    J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity.
    Venditti P; Napolitano G; Di Stefano L; Chiellini G; Zucchi R; Scanlan TS; Di Meo S
    Mol Cell Endocrinol; 2011 Jul; 341(1-2):55-62. PubMed ID: 21664427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyronamines inhibit plasma membrane and vesicular monoamine transport.
    Snead AN; Santos MS; Seal RP; Miyakawa M; Edwards RH; Scanlan TS
    ACS Chem Biol; 2007 Jun; 2(6):390-8. PubMed ID: 17530732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
    Rutigliano G; Bandini L; Sestito S; Chiellini G
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward deciphering the code to aminergic G protein-coupled receptor drug design.
    Tan ES; Groban ES; Jacobson MP; Scanlan TS
    Chem Biol; 2008 Apr; 15(4):343-53. PubMed ID: 18420141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation.
    Braulke LJ; Klingenspor M; DeBarber A; Tobias SC; Grandy DK; Scanlan TS; Heldmaier G
    J Comp Physiol B; 2008 Feb; 178(2):167-77. PubMed ID: 17912534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyronamines are substrates for human liver sulfotransferases.
    Pietsch CA; Scanlan TS; Anderson RJ
    Endocrinology; 2007 Apr; 148(4):1921-7. PubMed ID: 17204552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution and cardiac metabolism of 3-iodothyronamine.
    Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R
    Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.